Joy Wolfram's mission is to essentially reshape what we know about the medical landscape. Here's how she is positioning Australia as a global leader in extracellular vesicle medicine.
Associate Professor Joy Wolfram leads a nanomedicine and extracellular vesicle research program with the goal of developing innovative approaches that bring the next generation of treatments and diagnostics directly to the clinic.
Liposomes are self-assembling lipid-based nanoparticles that enclose an aqueous core. An advantage of liposomes is versatility in terms of efficient loading of both hydrophilic and hydrophobic therapeutics.
On International Womens’ Day, we asked AIBN’s Associate Professor Joy Wolfram what advice she would give to her 16-year-old self if she could mentor a younger Joy.
